Oren Gilad

2023

In 2023, Oren Gilad earned a total compensation of $877.4K as President and Chief Executive Officer at Aprea Therapeutics, a 16% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$246,950
Option Awards$60,160
Salary$550,000
Stock Awards$20,320
Total$877,430

Gilad received $550K in salary, accounting for 63% of the total pay in 2023.

Gilad also received $247K in non-equity incentive plan, $60.2K in option awards and $20.3K in stock awards.

Rankings

In 2023, Oren Gilad's compensation ranked 1,356th out of 3,006 executives tracked by ExecPay. In other words, Gilad earned more than 54.9% of executives.

ClassificationRankingPercentile
All
1,356
out of 3,006
55th
Division
Manufacturing
813
out of 1,650
51st
Major group
Chemicals And Allied Products
537
out of 918
42nd
Industry group
Drugs
524
out of 881
41st
Industry
Pharmaceutical Preparations
364
out of 637
43rd
Source: SEC filing on April 25, 2024.

Gilad's colleagues

We found two more compensation records of executives who worked with Oren Gilad at Aprea Therapeutics in 2023.

2023

John Hamill

Aprea Therapeutics

Chief Financial Officer

2023

Scott Coiante

Aprea Therapeutics

Chief Financial Officer

News

You may also like